retatrutide phase 2 trial results VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Delivers Significant Hemoglobin A1C

BIOMDECINE & PHARMACOTHRAPIE , 127 , 1-13

Injecting slowly, using a fresh needle, and letting the alcohol swab dry completely before injection all help minimize discomfort at either site

Keywords: glucagon-like peptide-1, neuroprotection, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, obesity, tirzepatide, Type 2 diabetes 1

Always work with your healthcare provider regarding your medication, nutrition, and any health concerns

You should not use Mounjaro if you have a personal or family history of a rare thyroid cancer (MEDULLARY thyroid carcinoma) or a genetic endocrine tumor syndrome, as medications like tirzepatide and other GLP-1 agonists carry a precaution for these